Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cell Reports|December 3, 2014
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven LeukemogenesisAnindya Chatterjee, Joydeep Ghosh, Baskar Ramdas, et al.
JCI Insight|May 10, 2016
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemiaKatherine A Minson, Catherine C Smith, Deborah DeRyckere, et al.
Blood Cancer Journal|May 31, 2022
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenibAlexander E Perl, Naoko Hosono, Pau Montesinos, et al.
Blood|October 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AMLBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemiaGabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
The Lancet. Oncology|June 4, 2018
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trialJorge Cortes, Alexander E Perl, Hartmut Döhner, et al.
Nature|January 28, 2021
Ebola virus antibody decay-stimulation in a high proportion of survivorsCharlene Adaken, Janet T Scott, Raman Sharma, et al.
Cancer Discovery|May 16, 2019
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid LeukemiaChristine M McMahon, Timothy Ferng, Jonathan Canaani, et al.
Nature Communications|September 18, 2024
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemiaCheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, et al.
Pageof 8